Overview

Prucalopride Effects on Subjects With Chronic Non-cancer Pain Suffering From Opioid Induced Constipation

Status:
Terminated
Trial end date:
2012-08-13
Target enrollment:
Participant gender:
Summary
The study will evaluate the efficacy, safety and tolerability of prucalopride over 12 weeks of treatment in subjects aged 18 years and older with chronic non-cancer pain, suffering from opioid induced constipation.
Phase:
Phase 3
Details
Lead Sponsor:
Shire
Treatments:
Analgesics, Opioid
Prucalopride